Insider Trading Alert - TYL, OPK, SRPT, HAL And MLNX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 14, 2013, 154 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $292.50 to $467,462,888.00.

Highlighted Stocks Traded by Insiders:

Tyler Technologies (TYL) - FREE Research Report

Marr John S Jr who is President and CEO at Tyler Technologies sold 50,000 shares at $96.51 on Nov. 14, 2013. Following this transaction, the President and CEO owned 497,971 shares meaning that the stake was reduced by 9.12% with the 50,000 share transaction.

The shares most recently traded at $97.74, up $1.23, or 1.26% since the insider transaction.

The average volume for Tyler Technologies has been 153,200 shares per day over the past 30 days. Tyler Technologies has a market cap of $3.2 billion and is part of the technology sector and computer software & services industry. Shares are up 101.88% year to date as of the close of trading on Thursday.

Tyler Technologies, Inc. provides integrated information management solutions and services for the public sector with a focus on local governments in the United States and internationally. The company has a P/E ratio of 88.1. Currently there are 3 analysts that rate Tyler Technologies a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TYL - FREE

TheStreet Quant Ratings rates Tyler Technologies as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Tyler Technologies Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Opko Health (OPK) - FREE Research Report

Frost Phillip Md Et Al who is CEO & Chairman at Opko Health bought 14,500 shares at $10.07 on Nov. 14, 2013. Following this transaction, the CEO & Chairman owned 137.0 million shares meaning that the stake was reduced by 0.01% with the 14,500 share transaction.

The shares most recently traded at $10.05, down $0.02, or 0.25% since the insider transaction.

The average volume for Opko Health has been 4.8 million shares per day over the past 30 days. Opko Health has a market cap of $4.2 billion and is part of the health care sector and health services industry. Shares are up 112.47% year to date as of the close of trading on Thursday.

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and feeble growth in the company's earnings per share. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Sarepta Therapeutics (SRPT) - FREE Research Report

Chase Anthony R who is Director at Sarepta Therapeutics bought 10,000 shares at $13.95 on Nov. 14, 2013. Following this transaction, the Director owned 41,744 shares meaning that the stake was reduced by 31.5% with the 10,000 share transaction.

Aphale Jayant who is SVP Technical Operations at Sarepta Therapeutics sold 15,933 shares at $12.56 on Nov. 14, 2013. Following this transaction, the SVP Technical Operations owned 8,500 shares meaning that the stake was reduced by 65.21% with the 15,933 share transaction.

The shares most recently traded at $14.18, up $1.62, or 11.42% since the insider transaction. Historical insider transactions for Sarepta Therapeutics go as follows:

  • 12-Week # shares bought: 6,500
  • 24-Week # shares bought: 25,500

The average volume for Sarepta Therapeutics has been 2.7 million shares per day over the past 30 days. Sarepta Therapeutics has a market cap of $484.4 million and is part of the health care sector and drugs industry. Shares are down 50.04% year to date as of the close of trading on Thursday.

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. Currently there are 6 analysts that rate Sarepta Therapeutics a buy, 2 analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SRPT - FREE

TheStreet Quant Ratings rates Sarepta Therapeutics as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and feeble growth in its earnings per share. Get the full Sarepta Therapeutics Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Halliburton Company (HAL) - FREE Research Report

Brown James S who is President - Western Hemisphere at Halliburton Company sold 22,926 shares at $54.90 on Nov. 14, 2013. Following this transaction, the President - Western Hemisphere owned 315,594 shares meaning that the stake was reduced by 6.77% with the 22,926 share transaction.

The shares most recently traded at $56.29, up $1.39, or 2.46% since the insider transaction. Historical insider transactions for Halliburton Company go as follows:

  • 4-Week # shares sold: 45,170
  • 12-Week # shares sold: 153,644
  • 24-Week # shares sold: 232,802

The average volume for Halliburton Company has been 9.4 million shares per day over the past 30 days. Halliburton Company has a market cap of $47.1 billion and is part of the basic materials sector and energy industry. Shares are up 60.1% year to date as of the close of trading on Thursday.

Halliburton Company provides a range of services and products for the exploration, development, and production of oil and natural gas to oil and gas companies worldwide. The company operates in two segments, Completion and Production, and Drilling and Evaluation. The stock currently has a dividend yield of 1.08%. The company has a P/E ratio of 26.6. Currently there are 18 analysts that rate Halliburton Company a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HAL - FREE

TheStreet Quant Ratings rates Halliburton Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Halliburton Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Mellanox Technologies (MLNX) - FREE Research Report

Baharav Dov who is Director at Mellanox Technologies bought 57,739 shares at $34.64 on Nov. 14, 2013. Following this transaction, the Director owned 66,906 shares meaning that the stake was reduced by 629.86% with the 57,739 share transaction.

The shares most recently traded at $38.65, up $4.01, or 10.38% since the insider transaction. Historical insider transactions for Mellanox Technologies go as follows:

  • 4-Week # shares sold: 3,195
  • 12-Week # shares sold: 3,683
  • 24-Week # shares sold: 5,683

The average volume for Mellanox Technologies has been 823,900 shares per day over the past 30 days. Mellanox Technologies has a market cap of $1.5 billion and is part of the technology sector and electronics industry. Shares are down 40.58% year to date as of the close of trading on Thursday.

Mellanox Technologies, Ltd., a fabless semiconductor company, produces and supplies semiconductor interconnect products for computing, storage, and communications applications in the high-performance computing, Web 2.0, storage, financial services, database, cloud, and embedded markets. The company has a P/E ratio of 705.7. Currently there are 3 analysts that rate Mellanox Technologies a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MLNX - FREE

TheStreet Quant Ratings rates Mellanox Technologies as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full Mellanox Technologies Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

A Stock Market Pullback Is Imminent and These 28 Stocks Will Help You Survive It
Tyler Technologies (TYL) Is Water-Logged And Getting Wetter Today

Tyler Technologies (TYL) Is Water-Logged And Getting Wetter Today

MANH, TYL And MBLY, 3 Computer Software & Services Stocks Pushing The Industry Lower

MANH, TYL And MBLY, 3 Computer Software & Services Stocks Pushing The Industry Lower

Brexit Comes at a Particularly Bad Time for Software Companies

Brexit Comes at a Particularly Bad Time for Software Companies

Strong On High Relative Volume: Tyler Technologies (TYL)

Strong On High Relative Volume: Tyler Technologies (TYL)